相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Association between metastatic sites and first-line pembrolizumab treatment outcome for advanced non-small cell lung cancer with high PD-L1 expression: a retrospective multicenter cohort study
Hayato Kawachi et al.
INVESTIGATIONAL NEW DRUGS (2020)
Prognostic clinical factors in patients affected by non-small-cell lung cancer receiving Nivolumab
Francesco Pantano et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2020)
Clinicopathologic correlates of first-line pembrolizumab effectiveness in patients with advanced NSCLC and a PD-L1 expression of ≥ 50%
Alessio Cortellini et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2020)
Outcome of Patients with Non-Small Cell Lung Cancer and Brain Metastases Treated with Checkpoint Inhibitors
Lizza E. L. Hendriks et al.
JOURNAL OF THORACIC ONCOLOGY (2019)
Fluorine-18-fluorodeoxyglucose-positron emission tomography evaluation in metastatic bone lesions in lung cancer: Possible prediction of pain and skeletal-related events
Daisuke Gomi et al.
THORACIC CANCER (2019)
Evaluation of the Lung Immune Prognostic Index for Prediction of Survival and Response in Patients Treated With Atezolizumab for NSCLC: Pooled Analysis of Clinical Trials
Michael J. Sorich et al.
JOURNAL OF THORACIC ONCOLOGY (2019)
Combination of denosumab and immune checkpoint inhibition: experience in 29 patients with metastatic melanoma and bone metastases
Yenny Angela et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2019)
Differences in Tumor Microenvironment Dictate T Helper Lineage Polarization and Response to Immune Checkpoint Therapy
Shiping Jiao et al.
CELL (2019)
Bone metastases and immunotherapy in patients with advanced non-small-cell lung cancer
Lorenza Landi et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Lesion-Level Response Dynamics to Programmed Cell Death Protein (PD-1) Blockade
Juan C. Osorio et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Non-Small Cell Lung Cancer, Version 1.2020 Featured Updates to the NCCN Guidelines
David S. Ettinger et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2019)
PD-1 blockade in combination with zoledronic acid to enhance the antitumor efficacy in the breast cancer mouse model
Yuan Li et al.
BMC CANCER (2018)
Pembrolizumab plus Chemotherapy in Metastatic Non-Small-Cell Lung Cancer
L. Gandhi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Organ-specific response to nivolumab in patients with non-small cell lung cancer (NSCLC)
Sabine Schmid et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2018)
Impact of denosumab use on the survival of untreated non-squamous non-small cell lung cancer patients with bone metastases
Hibiki Udagawa et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2017)
Overcoming immunosuppression in bone metastases
Zachary Z. Reinstein et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2017)
Effect of Bisphosphonates, Denosumab, and Radioisotopes on Bone Pain and Quality of Life in Patients with Non-Small Cell Lung Cancer and Bone Metastases: A Systematic Review
Lizza E. L. Hendriks et al.
JOURNAL OF THORACIC ONCOLOGY (2016)
Specific organ metastases and survival in metastatic non-small-cell lung cancer
Tomohiro Tamura et al.
MOLECULAR AND CLINICAL ONCOLOGY (2015)
Bone metastasis, skeletal-related events, and mortality in lung cancer patients: A Danish population-based cohort study
Karynsa Cetin et al.
LUNG CANCER (2014)
Overall Survival Improvement in Patients with Lung Cancer and Bone Metastases Treated with Denosumab Versus Zoledronic Acid Subgroup Analysis from a Randomized Phase 3 Study
Giorgio Vittorio Scagliotti et al.
JOURNAL OF THORACIC ONCOLOGY (2012)
Randomized, Double-Blind Study of Denosumab Versus Zoledronic Acid in the Treatment of Bone Metastases in Patients With Advanced Cancer (Excluding Breast and Prostate Cancer) or Multiple Myeloma
David H. Henry et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Epidemiology and Treatment Costs of Bone Metastases from Lung Cancer A French Prospective, Observational, Multicenter Study (GFPC 0601)
Chantal Decroisette et al.
JOURNAL OF THORACIC ONCOLOGY (2011)
Research electronic data capture (REDCap)-A metadata-driven methodology and workflow process for providing translational research informatics support
Paul A. Harris et al.
JOURNAL OF BIOMEDICAL INFORMATICS (2009)
Long-term efficacy and safety of zoledronic acid in the treatment of skeletal metastases in patients with nonsmall cell lung carcinoma and other solid tumors - A randomized, phase III, double-blind, placebo-controlled trial
LS Rosen et al.
CANCER (2004)
Zoledronic acid versus placebo in the treatment of skeletal metastases in patients with lung cancer and other solid tumors: A phase III, double-blind, randomized trial - The zoledronic acid lung cancer and other solid tumors study group
LS Rosen et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
分享论文
